Skip to main content
Top
Published in: Clinical Rheumatology 4/2010

01-04-2010 | Case Report

Graft-versus-host disease-related polymyositis

Authors: Helene Maillard-Lefebvre, Sandrine Morell-Dubois, Marc Lambert, Hilaire Charlanne, David Launay, Eric Hachulla, Ibrahim Yakoub-Agha, Pierre-Yves Hatron

Published in: Clinical Rheumatology | Issue 4/2010

Login to get access

Abstract

Chronic graft-versus-host disease (GVHD) sometimes mimics autoimmune diseases. We report the case of a 39-year-old patient who presented atypical polymyositis without elevated creatinine phosphokinase, related to a chronic GVHD following interruption of immunosuppressive treatment. Treatment with cyclosporine and corticosteroids resulted in complete and sustained remission of the polymyositis. The symptoms of chronic GVHD-related polymyositis are indistinguishable from those of idiopathic polymyositis. The context of transplantation and a decrease or interruption of prophylaxis suggest the diagnosis of GVHD-related polymyositis, especially if other manifestations of GVHD are associated. A suitably adapted treatment (association of corticotherapy and cyclosporine) improves polymyositis, and in most cases, a normal clinical state is achieved even if the symptoms were severe.
Literature
1.
go back to reference Vinzio S, Lioure B, Grunenberger F, Schlienger JL, Goichot B (2004) Auto-immune-like disease post-bone marrow transplantation. Rev Med Interne 25:514–523CrossRefPubMed Vinzio S, Lioure B, Grunenberger F, Schlienger JL, Goichot B (2004) Auto-immune-like disease post-bone marrow transplantation. Rev Med Interne 25:514–523CrossRefPubMed
3.
go back to reference Sullivan KM, Agura E, Anasetti C et al (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250–259PubMed Sullivan KM, Agura E, Anasetti C et al (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250–259PubMed
4.
go back to reference Lin PC, Hsiao LT, Chen PM (2005) Acute polymyositis after donor lymphocyte infusion. Eur J Haematol 74:166–168CrossRefPubMed Lin PC, Hsiao LT, Chen PM (2005) Acute polymyositis after donor lymphocyte infusion. Eur J Haematol 74:166–168CrossRefPubMed
5.
go back to reference Fukunaga H, Osame M, Sakashita I, Sameshima H, Igata A (1987) Clinical and myopathological findings in polymyositis. No To Shinkei 39:657–661PubMed Fukunaga H, Osame M, Sakashita I, Sameshima H, Igata A (1987) Clinical and myopathological findings in polymyositis. No To Shinkei 39:657–661PubMed
6.
go back to reference Cherin P, Herson S, Crevon MC, Hauw JJ, Cervera P, Galanaud P, Emilie D (1996) Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol 23:1135–1142PubMed Cherin P, Herson S, Crevon MC, Hauw JJ, Cervera P, Galanaud P, Emilie D (1996) Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis. J Rheumatol 23:1135–1142PubMed
7.
go back to reference Stevens AM, Sullivan KM, Nelson JL (2003) Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford) 42:34–39CrossRef Stevens AM, Sullivan KM, Nelson JL (2003) Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford) 42:34–39CrossRef
8.
go back to reference Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337–345CrossRefPubMed Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337–345CrossRefPubMed
9.
go back to reference Parker PM, Openshaw H, Forman SJ (1997) Myositis associated with graft-versus-host disease. Curr Opin Rheumatol 9:513–519CrossRefPubMed Parker PM, Openshaw H, Forman SJ (1997) Myositis associated with graft-versus-host disease. Curr Opin Rheumatol 9:513–519CrossRefPubMed
10.
go back to reference Hanslik T, Jaccard A, Guillon JM, Vernant JP, Wechsler B, Godeau P (1993) Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin. J Am Acad Dermatol 28:492–493CrossRefPubMed Hanslik T, Jaccard A, Guillon JM, Vernant JP, Wechsler B, Godeau P (1993) Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin. J Am Acad Dermatol 28:492–493CrossRefPubMed
11.
go back to reference Courtney AE, CD C, Herron B, McCarron MO, Connolly JK, Jefferson JA (2004) Acute polymyositis following renal transplantation. Am J Transplant 4:1204–1207CrossRefPubMed Courtney AE, CD C, Herron B, McCarron MO, Connolly JK, Jefferson JA (2004) Acute polymyositis following renal transplantation. Am J Transplant 4:1204–1207CrossRefPubMed
Metadata
Title
Graft-versus-host disease-related polymyositis
Authors
Helene Maillard-Lefebvre
Sandrine Morell-Dubois
Marc Lambert
Hilaire Charlanne
David Launay
Eric Hachulla
Ibrahim Yakoub-Agha
Pierre-Yves Hatron
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1350-5

Other articles of this Issue 4/2010

Clinical Rheumatology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.